- Report
- February 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- March 2023
- 648 Pages
Global
From €9600EUR$9,995USD£8,265GBP
- Report
- November 2019
United States
From €7679EUR$7,995USD£6,611GBP
- Report
- September 2019
Europe
From €8639EUR$8,995USD£7,438GBP
- Report
- March 2024
- 123 Pages
From €1441EUR$1,500USD£1,240GBP
- Report
- October 2022
- 67 Pages
North America
From €1441EUR$1,500USD£1,240GBP
From €7203EUR$7,500USD£6,202GBP
From €7203EUR$7,500USD£6,202GBP
- Report
- December 2021
- 280 Pages
Global
From €3565EUR$3,712USD£3,069GBP
- Book
- October 2011
- 360 Pages
Europe
The Cerebrospinal Fluid (CSF) market is a subset of the Neurology market, focusing on the diagnosis and treatment of neurological disorders. CSF is a clear, colorless fluid that circulates around the brain and spinal cord, providing protection and nourishment to the central nervous system. It is used to diagnose a variety of neurological conditions, including hydrocephalus, meningitis, and multiple sclerosis. CSF testing is also used to monitor the effectiveness of treatments for these conditions.
The CSF market is composed of a variety of companies, including diagnostic laboratories, medical device manufacturers, and pharmaceutical companies. Diagnostic laboratories provide CSF testing services, while medical device manufacturers produce the equipment used to collect and analyze CSF samples. Pharmaceutical companies develop and market drugs used to treat neurological conditions. Examples of companies in the CSF market include Abbott Laboratories, Becton Dickinson, and Roche Diagnostics. Show Less Read more